In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Chiasma, Inc.. Trade Record

NASDAQ:CHMA Chiasma, Inc. stock gains 26.02% Exit Oct 2, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart CHMA Sep 13, 2018, priceSeries
About Chiasma, Inc.

Chiasma, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing oral forms of therapies for patients suffering from orphan diseases. Its product candidate is octreotide capsules or MYCAPSSA, which has completed Phase III clinical trial for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Newton, Massachusetts.

Trade Information
Trade Type
LONG
ReliabilityScore™
85.19
Entry Date
Sep 13, 2018
Entry Price
2.60
Sell Date
Oct 2, 2018
Sell Price
3.28
Net Gain
26.02%
Hold Time
13 Trading Days